American Diabetes Association Pathway to Stop Diabetes Solicitation

Please see the full solicitation for complete information about the funding opportunity. Below is a summary assembled by the Research & Innovation Office (RIO).

Program Summary 

Pathway seeks to bring new investigators and new perspectives to diabetes research. Supporting scientists with different backgrounds and experience is critical to achieving that objective. Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological, and health services research relevant to any type of diabetes, diabetes-related disease state or complication. Pathway solicits nominations for candidates in all disciplines as applied to diabetes including medicine, biology, chemistry, computing, physics, mathematics and engineering. In addition, nomination of scientists from diverse backgrounds, including minority groups that are underrepresented in biomedical research, is strongly encouraged.

The Pathways Program has three award types:

  1. Initiator Award for postdoctoral fellows,
  2. Accelerator Award for early career faculty, and
  3. Visionary Award for established investigators who are new to diabetes research


CU Internal Deadline: 11:59pm MST April 24, 2019

Sponsor Application Deadline: 3:00pm MST July 1, 2019

Internal Application Requirements (all in PDF format)

  • Project Summary (up to 2 pages): Please include the following elements: purpose, research strategy, research importance to people with diabetes, innovative nature of research, why the research is uniquely suited for this program rather than traditional grant programs, most significant research accomplishments to date and personal qualities/characteristics required for these accomplishments, long-term commitment to diabetes research.
  • PI CV / Biosketch
  • Budget Overview (up to 1 page): A basic budget outlining project costs is sufficient; detailed OCG budgets are not required.

To access the online application, visit:


Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support. Only one repeat nomination of an individual applicant will be considered.

  • Initiator Award: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. 
  • Accelerator Award: Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for, or received, an R01/U01 renewal or a second R01/U01 award. 
  • Visionary Award: Applicants must hold independent faculty positions and have demonstrated significant productivity in their current field of research. Applicants cannot have previously received national grant support (NIH, NIDDK, ADA, JDRF, etc.), as either a PI or Co-PI, in diabetes or diabetes-related research.

Limited Submission Guidelines

Each institution is allowed a maximum of one nomination per grant cycle to one of the Pathway Program Award types: Initiator, Accelerator, or Visionary.

Award Information

Award Amount:

  • Initiator Award: Maximum funding of $100,000/year in Phase I, and $325,000/year in Phase II 
  • Accelerator Award: Maximum funding of $325,000/year
  • Visionary Award: Maximum funding of $325,000/year in Phase I, $325,000/year in Phase II

Award Duration:

  • Initiator Award: Up to 7 years
  • Accelerator Award: Up to 5 years
  • Visionary Award: Up to 5 years